LENZ Therapeutics's total assets for Q1 2026 were $272.54M, a decrease of -10.90% from the previous quarter. LENZ total liabilities were $26.04M for the fiscal quarter, a 20.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.